Pure Financial Advisors LLC Raises Stock Position in Cigna Group $CI

Pure Financial Advisors LLC grew its holdings in Cigna Group (NYSE:CI) by 57.6% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,767 shares of the health services provider’s stock after acquiring an additional 646 shares during the period. Pure Financial Advisors LLC’s holdings in Cigna Group were worth $584,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the business. Price T Rowe Associates Inc. MD raised its stake in shares of Cigna Group by 10.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock valued at $3,966,690,000 after acquiring an additional 1,094,327 shares during the period. Massachusetts Financial Services Co. MA increased its stake in Cigna Group by 0.9% during the 1st quarter. Massachusetts Financial Services Co. MA now owns 11,654,993 shares of the health services provider’s stock worth $3,834,493,000 after buying an additional 98,715 shares during the period. Dodge & Cox increased its stake in Cigna Group by 1.3% during the 1st quarter. Dodge & Cox now owns 8,889,733 shares of the health services provider’s stock worth $2,924,722,000 after buying an additional 117,125 shares during the period. GQG Partners LLC increased its stake in Cigna Group by 21.5% during the 1st quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock worth $1,607,716,000 after buying an additional 865,092 shares during the period. Finally, Parnassus Investments LLC increased its stake in Cigna Group by 3.1% during the 1st quarter. Parnassus Investments LLC now owns 2,885,583 shares of the health services provider’s stock worth $949,357,000 after buying an additional 86,602 shares during the period. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Trading Up 4.8%

NYSE CI opened at $311.24 on Friday. Cigna Group has a one year low of $256.89 and a one year high of $358.88. The company has a 50-day simple moving average of $292.41 and a 200-day simple moving average of $309.81. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. The firm has a market capitalization of $83.08 billion, a PE ratio of 16.99, a price-to-earnings-growth ratio of 0.87 and a beta of 0.45.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, beating the consensus estimate of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The business had revenue of $67.13 billion during the quarter, compared to analyst estimates of $62.61 billion. During the same period in the previous year, the business posted $6.72 EPS. The company’s quarterly revenue was up 11.0% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, equities analysts forecast that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th were issued a $1.51 dividend. The ex-dividend date of this dividend was Thursday, September 4th. This represents a $6.04 annualized dividend and a dividend yield of 1.9%. Cigna Group’s payout ratio is 32.97%.

Analyst Ratings Changes

Several equities research analysts recently issued reports on CI shares. Wall Street Zen downgraded shares of Cigna Group from a “buy” rating to a “hold” rating in a research note on Friday. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Cigna Group in a research note on Saturday, September 27th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $365.00 price target on shares of Cigna Group in a research note on Tuesday, August 26th. TD Cowen raised shares of Cigna Group to a “strong-buy” rating in a report on Monday, June 23rd. Finally, Robert W. Baird set a $372.00 price objective on shares of Cigna Group in a report on Thursday, August 14th. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $371.81.

Insider Activity at Cigna Group

In other news, insider Nicole S. Jones sold 28,526 shares of Cigna Group stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the completion of the transaction, the insider directly owned 25,648 shares of the company’s stock, valued at approximately $7,694,400. The trade was a 52.66% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 0.70% of the company’s stock.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.